Inhibiting eEF2K-mediated autophagy has been reported to enhance the antitumor effect of MK-2206, an AKT inhibitor, on human nasopharyngeal carcinoma and human glioma cells [65,66]. This evidence concerns the gene EEF2K and nasopharyngeal carcinoma.